Cargando…
PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma
Increasing evidence suggests that PRMT5, a protein arginine methyltransferase, has roles in cell growth regulation and cancer development. However, the role of PRMT5 in hepatocellular carcinoma (HCC) progression remains unclear. Here, we showed that PRMT5 expression was frequently upregulated in HCC...
Autores principales: | Jiang, Hai, Zhu, Yue, Zhou, Zhenyu, Xu, Junyang, Jin, Shaowen, Xu, Kang, Zhang, Heyun, Sun, Qing, Wang, Jie, Xu, Junyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852340/ https://www.ncbi.nlm.nih.gov/pubmed/29441724 http://dx.doi.org/10.1002/cam4.1360 |
Ejemplares similares
-
PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK‐3β/Snail signaling
por: Jiang, Hai, et al.
Publicado: (2018) -
BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1
por: LIU, CHUNHUI, et al.
Publicado: (2015) -
BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells
por: Tsui, Ke‐Hung, et al.
Publicado: (2017) -
The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma
por: Zhang, Xuan, et al.
Publicado: (2017) -
Arginine methylation of SHANK2 by PRMT7 promotes human breast cancer metastasis through activating endosomal FAK signalling
por: Liu, Yingqi, et al.
Publicado: (2020)